Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Maeurer

Showing results (11-20 of 206) with videos related to

Pageof 21
Sort By:
The American Journal of Medicine|May 22, 2012
Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infectionsGiovanni Ferrara, Alimuddin Zumla, Markus Maeurer
The New England Journal of Medicine|September 11, 2014
Pregnancy and infectionAlimuddin Zumla, Matthew Bates, Markus Maeurer
Current Opinion in Pulmonary Medicine|March 19, 2016
Host-directed therapies for antimicrobial resistant respiratory tract infectionsMarkus Maeurer, Martin Rao, Alimuddin Zumla
Annals of Translational Medicine|June 6, 2015
Host directed therapies (HDTs) and immune response signatures: insights into a role for interleukin-32Markus Maeurer, Martin Rao, Alimuddin Zumla
The Lancet. Respiratory Medicine|March 30, 2018
B cells or T cells in TB: a continuing conundrumMarkus Maeurer, Martin Rao, Alimuddin Zumla
Current Opinion in Pulmonary Medicine|March 19, 2019
Precision medicine in the clinical management of respiratory tract infections including multidrug-resistant tuberculosis: learning from innovations in immuno-oncologyMartin Rao, Dario Ligeiro, Markus Maeurer
The Lancet. Respiratory Medicine|March 2, 2015
Host-directed therapy: tuberculosis vaccine developmentMartin Rao, Alimuddin Zumla, Markus Maeurer
Trends in Immunology|October 6, 2010
Humoral 'reactome' profiles using peptide microarray chipsDavide Valentini, Simani Gaseitsiwe, Markus Maeurer
Lancet (London, England)|September 16, 2015
Corticosteroid therapy for pneumoniaAlimuddin Zumla, Matthew Bates, Markus Maeurer
Current Opinion in Pulmonary Medicine|March 6, 2012
Update on viral infections in lung transplantationMichael Uhlin, Jonas Mattsson, Markus Maeurer
Pageof 21

Showing results (11-20 of 206) with videos related to

Sort By:
Pageof 21
The American Journal of Medicine|May 22, 2012
Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infectionsGiovanni Ferrara, Alimuddin Zumla, Markus Maeurer
The New England Journal of Medicine|September 11, 2014
Pregnancy and infectionAlimuddin Zumla, Matthew Bates, Markus Maeurer
Current Opinion in Pulmonary Medicine|March 19, 2016
Host-directed therapies for antimicrobial resistant respiratory tract infectionsMarkus Maeurer, Martin Rao, Alimuddin Zumla
Annals of Translational Medicine|June 6, 2015
Host directed therapies (HDTs) and immune response signatures: insights into a role for interleukin-32Markus Maeurer, Martin Rao, Alimuddin Zumla
The Lancet. Respiratory Medicine|March 30, 2018
B cells or T cells in TB: a continuing conundrumMarkus Maeurer, Martin Rao, Alimuddin Zumla
Current Opinion in Pulmonary Medicine|March 19, 2019
Precision medicine in the clinical management of respiratory tract infections including multidrug-resistant tuberculosis: learning from innovations in immuno-oncologyMartin Rao, Dario Ligeiro, Markus Maeurer
The Lancet. Respiratory Medicine|March 2, 2015
Host-directed therapy: tuberculosis vaccine developmentMartin Rao, Alimuddin Zumla, Markus Maeurer
Trends in Immunology|October 6, 2010
Humoral 'reactome' profiles using peptide microarray chipsDavide Valentini, Simani Gaseitsiwe, Markus Maeurer
Lancet (London, England)|September 16, 2015
Corticosteroid therapy for pneumoniaAlimuddin Zumla, Matthew Bates, Markus Maeurer
Current Opinion in Pulmonary Medicine|March 6, 2012
Update on viral infections in lung transplantationMichael Uhlin, Jonas Mattsson, Markus Maeurer
Pageof 21